Denosumab 60mg/ml (pre-filled syringe)

Auto-translated from French

Original title: Denosumab 60mg/ml (seringue préremplie)

Healthcare Public Procurement (HeCaPP)

Published: Sep 16, 2026

Updated: Sep 16, 2026

Source: belgium_eprocurement

About This Opportunity

This is a supplies contract in the health and medical services and information and communication technology sectors, with a focus on artificial intelligence. Located in Belgium, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before October 19, 2026.

Published through Belgium e-Procurement, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: French

This procurement, originating from Belgium and accessible through the national e-procurement portal, concerns the supply of 'Denosumab 60mg/ml (seringue préremplie)', which is Denosumab 60mg/ml in a pre-filled syringe. This indicates a requirement for a specific pharmaceutical product. The contracting authority is likely a healthcare provider in Belgium, such as a hospital, a public health service, or a central purchasing body for medicines. Typical requirements for supplying pharmaceuticals include adherence to strict quality and regulatory standards (e.g., GMP - Good Manufacturing Practice), ensuring product traceability, maintaining cold chain logistics if necessary, and providing proof of marketing authorization. Bidders must be licensed pharmaceutical suppliers. The tender will specify the required quantities, dosage, packaging, and delivery schedules. Pricing will be a significant evaluation factor, alongside the reliability of supply, the supplier's regulatory compliance, and potentially their ability to offer related services. The focus is on securing a consistent and compliant supply of this critical medication.

Data provenance

This notice is sourced from Belgium e-Procurement and was originally published on September 16, 2026. Last refreshed today. Original language: French. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Healthcare Public Procurement (HeCaPP)

Healthcare Public Procurement (HeCaPP) has issued 65 procurement notices on BidsFactory, including 7 currently open and 27 awarded contracts. Activity concentrates in Health & Medical, Information & Communication Technology, and Industry & Manufacturing. All notices are published for Belgium. Notices are distributed via Belgium e-Procurement and TED - Tenders Electronic Daily (EU). Most recent publication: September 16, 2026.

Frequently asked questions about this tender

Where will the contract be performed?

The contract is for delivery in Belgium. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Belgium e-Procurement to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is October 19, 2026. You have 33 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by Healthcare Public Procurement (HeCaPP) in Belgium. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.